CQC-regulated clinics & online consultations
Posted on October 29, 2026 by Sally-Anne Turner
You’re managing your depression with medication, and now you’re considering weight loss injections. Perhaps your antidepressant has contributed to weight gain, or maybe you’ve struggled with weight alongside your mental health challenges for years. Now you’re wondering: can I safely take these medications together? Will they interact? Could combining them make my depression worse – or might it actually help?
These questions deserve clear, evidence-based answers. The relationship between weight loss injections like Wegovy, Mounjaro and Saxenda and antidepressant medications is an area of growing interest in healthcare. While weight loss injections and mental health is a broader topic, this guide focuses specifically on what happens when you combine these treatments with antidepressants.
The short answer is that many people can use weight loss injections alongside antidepressants. But the details matter – the type of antidepressant you’re taking, your individual response to both medications, and the monitoring you receive all play crucial roles in ensuring safe, effective treatment.
Before we explore how these medications interact, it helps to understand what each one does in your body and brain.
Antidepressants work primarily by influencing neurotransmitters – chemical messengers involved in regulating mood, sleep, appetite and other functions. Different classes of antidepressants work in different ways, which is why their effects on weight can vary considerably.
SSRIs (selective serotonin reuptake inhibitors) like sertraline, fluoxetine, citalopram and escitalopram increase the availability of serotonin in the brain. Serotonin influences mood, but it also plays a role in appetite regulation. Some people initially experience reduced appetite or weight loss when starting SSRIs, while longer-term use can sometimes contribute to weight gain through mechanisms that aren’t fully understood.
Mirtazapine works differently. It affects certain serotonin and noradrenaline receptors and also blocks histamine receptors, which can contribute to increased appetite and sedation. This is why mirtazapine is particularly associated with weight gain, which can be distressing for some patients.
Other antidepressants like venlafaxine, duloxetine (SNRIs) and bupropion have their own mechanisms and potential effects on weight. Some are relatively weight-neutral, while others may contribute to weight changes in either direction. Bupropion is not routinely licensed as an antidepressant in the UK, although it is used for other indications.
The NHS guidance on antidepressants provides further information about their uses, side effects and why treatment should not be stopped suddenly without medical advice.
GLP-1 receptor agonists like Wegovy (semaglutide) mimic the action of a hormone your gut naturally produces after eating. They work in several ways: slowing gastric emptying, reducing appetite signals in your brain, helping regulate blood sugar levels and influencing pathways involved in food intake.
Mounjaro (tirzepatide) works slightly differently because it activates both GIP and GLP-1 receptors. It is therefore a dual GIP/GLP-1 receptor agonist rather than a GLP-1-only medication.
These medications influence receptors in several parts of the body, including brain regions involved in appetite regulation. Researchers are also investigating their effects on reward pathways and other neurological processes.
However, this does not mean that GLP-1 medications and antidepressants necessarily interact directly in the brain or that GLP-1 treatments have established antidepressant effects.
The reassuring news is that there are no universally recognised contraindications to combining GLP-1-based weight loss medications with all antidepressants. However, it would be inaccurate to say that interactions cannot occur.
One important consideration is gastric emptying. GLP-1-based medicines can delay the movement of food and medicines through the stomach, potentially affecting the absorption of some oral medications. The clinical significance varies according to the medicine involved.
There may also be overlapping effects. Both medication types can affect appetite, nausea and gastrointestinal function. Some antidepressants influence energy levels and sleep, while physical side effects from weight loss treatment can also affect how you feel.
This is why your prescriber should review your complete medication list rather than assuming that every combination is automatically safe.
SSRIs are among the most commonly prescribed antidepressants in the UK, making this combination particularly relevant for many people considering weight loss treatment.
Clinical trials of GLP-1-based weight loss treatments have included some participants taking antidepressants, including SSRIs. Available evidence has not established a general prohibition on combining these treatments.
However, this does not mean that every SSRI and GLP-1 combination has been studied extensively or that there is no possibility of adverse effects.
Some research has also explored whether GLP-1-based medicines might be associated with changes in depressive symptoms. Certain studies have reported improvements in mental wellbeing, although these findings may be influenced by weight loss, changes in physical health and other factors.
Importantly, GLP-1 medications are not licensed in the UK to treat depression, and they should not be expected to replace antidepressant treatment.
Potential explanations for improvements in wellbeing include better metabolic health, improved mobility, changes in quality of life and possible effects on neurological pathways. However, direct antidepressant effects remain an area of investigation rather than an established clinical benefit.
Both SSRIs and GLP-1 medications can cause nausea, particularly when you first start taking them or when doses are increased. When you’re taking both, this effect might feel more pronounced.
Gastrointestinal side effects from GLP-1 treatment are often more noticeable during dose escalation and may improve over time. However, persistent or severe symptoms should not simply be dismissed as part of the adjustment process.
Strategies that may help include eating smaller, more frequent meals, avoiding foods that worsen nausea and maintaining adequate hydration. Take your SSRI according to its specific instructions, including whether it should be taken with food.
If nausea prevents you from eating or drinking properly, contact your healthcare provider. Severe vomiting or dehydration can require urgent medical assessment.
Some SSRIs can cause initial anxiety or restlessness. If you experience increased anxiety after starting weight loss treatment, discuss this with your healthcare provider rather than assuming it’s a normal adjustment effect.
When you’re taking both medications, monitoring your mood is particularly important, especially if you have a history of severe or recurrent depression.
Your healthcare provider may ask about depressive symptoms, anxiety, sleep quality and any concerning thoughts. These check-ins help identify changes that need assessment, regardless of whether they’re related to medication.
Keep track of your mood yourself if you find this helpful. A simple mood journal can help you identify patterns. Are you feeling more tired than usual? Is your depression improving, staying stable or worsening? Are you experiencing more anxiety?
If your depression worsens while taking weight loss injections, it doesn’t automatically mean the medication is responsible. Life stressors, changes in physical health or fluctuations in your underlying condition may also contribute.
However, worsening depression always deserves attention, and your healthcare team can help determine the appropriate response.
Mirtazapine presents a particular consideration because it’s associated with increased appetite and weight gain in some patients. This makes the combination with weight loss medication especially relevant for people taking this antidepressant.
Mirtazapine’s effects on appetite are partly associated with its antihistamine activity and actions on other receptors involved in appetite regulation.
Many people taking mirtazapine report increased hunger, food cravings or larger portion sizes, although the extent of these changes varies.
The sedating effects of mirtazapine can also contribute indirectly to weight gain if tiredness reduces physical activity.
This weight gain isn’t necessarily about willpower or lack of self-control. Medication-related changes in appetite and energy can make weight management more difficult, and addressing these effects may require medical support.
This is a question many people taking mirtazapine ask, and it’s an area of clinical interest.
However, large, high-quality studies specifically examining whether GLP-1 medications reverse mirtazapine-associated weight gain are limited.
The mechanisms suggest a possible rationale: mirtazapine can increase appetite, while GLP-1-based medications reduce appetite through different pathways. Nevertheless, this does not establish that one medication reliably counteracts the effects of the other.
Some patients may lose weight while continuing mirtazapine, but individual outcomes depend on several factors, including the underlying condition, medication doses, dietary intake and overall health.
It would therefore be misleading to promise that weight loss injections will cancel out mirtazapine-related weight gain or to predict how much weight someone taking this combination will lose.
If you’re taking mirtazapine and considering weight loss injections, timing and expectations matter.
If you’ve recently started mirtazapine and are still adjusting to treatment, your clinician may recommend reviewing your mental health and medication response before introducing weight loss treatment.
However, if you’ve been taking mirtazapine for some time and have experienced significant weight gain, a weight management assessment may be appropriate.
The potential health effects of excess weight need to be considered alongside the benefits you’re receiving from mirtazapine.
Some people wonder whether they should switch antidepressants to one less associated with weight gain. This is a conversation to have with your psychiatrist or GP.
Switching antidepressants carries risks, including withdrawal symptoms, relapse or a poorer response to the replacement medication. If mirtazapine is effectively managing your depression, your clinician may prefer to explore weight management options rather than change a successful psychiatric treatment.
Mirtazapine’s sedating effects can complicate weight management. If you’re very drowsy, you might struggle to prepare meals or maintain physical activity.
Some people taking GLP-1-based medications also report fatigue, although this varies by treatment and individual response.
Mirtazapine is commonly taken at night because it can cause drowsiness. However, you should follow your prescribed instructions rather than changing the timing yourself.
If fatigue becomes problematic, discuss it with your healthcare provider. They can assess whether medication effects, inadequate nutrition, sleep problems or another medical issue may be contributing.
Any changes to mirtazapine dosing must be made under medical supervision.
While SSRIs and mirtazapine are common, many people take other types of antidepressants. Understanding the considerations for these medicines helps you know what to discuss with your prescriber.
SNRIs affect both serotonin and noradrenaline. Their effects on weight vary, and some people experience weight changes in either direction.
There is no general contraindication to using GLP-1-based weight loss treatment with all SNRIs. However, evidence about individual combinations is limited, so a medication review remains important.
One consideration is that venlafaxine, particularly at higher doses, can increase blood pressure in some patients. Weight loss may also influence blood pressure, making monitoring appropriate.
If your blood pressure changes significantly, your clinician may need to review your medications. Never adjust doses independently.
Bupropion affects dopamine and noradrenaline pathways and may be associated with weight loss in some patients.
However, bupropion is not routinely licensed in the UK as an antidepressant. It is used for smoking cessation under the brand name Zyban, and its use for depression would be outside its UK licensed indication.
There is insufficient evidence to recommend combining bupropion with GLP-1-based medications specifically to enhance weight loss.
If you’re taking bupropion, your prescriber should review the reason for treatment, your medical history and any relevant risks before considering weight loss medication.
Older tricyclic antidepressants like amitriptyline are still used for depression and other conditions, including certain chronic pain conditions.
Some tricyclics can cause weight gain, sedation and anticholinergic side effects.
There is limited direct evidence about individual tricyclic antidepressants used alongside GLP-1-based weight loss medicines. The combination is not automatically contraindicated, but a clinician should consider the potential for gastrointestinal effects, changes in oral medication absorption and other relevant medical risks.
If you’re taking a tricyclic that’s working well for you, weight management treatment may still be worth discussing if weight gain has become problematic.
Knowing what to anticipate helps you prepare for treatment and recognise what’s expected versus what needs attention.
Your body may need time to adjust to weight loss medication. During the first few weeks, nausea and other gastrointestinal side effects are common with some GLP-1-based treatments, particularly during dose escalation.
Your appetite may decrease noticeably. This can feel strange, particularly if your antidepressant has been increasing your appetite.
You might find yourself eating smaller portions or feeling full more quickly. Although appetite suppression is an intended treatment effect, you still need adequate nutrition and hydration.
Fatigue can occur, and if your antidepressant also causes sedation, you may notice increased tiredness. However, persistent fatigue should not automatically be attributed to medication adjustment.
Mood changes should also be taken seriously. Feeling flat, irritable or unusually anxious is not an established effect that everyone should expect when starting GLP-1 treatment.
If you experience new or worsening psychological symptoms, contact your healthcare provider rather than waiting several weeks to see whether they disappear.
As treatment progresses and you begin seeing changes in weight, you may notice improvements in mobility, physical health or quality of life.
Some people also report feeling more confident or positive about their progress. However, mood improvements are not guaranteed, and weight loss treatment should not be considered a treatment for depression.
This may also be a period when your relationship with food changes. If you’ve used eating as a coping mechanism for difficult emotions, you may need support developing alternative strategies.
Your antidepressant treatment should continue to be reviewed according to your individual needs.
If you notice your depression symptoms returning or worsening, seek medical advice. Your healthcare team can assess whether the changes relate to your mental health condition, medication effects, physical health or other factors.
Many people experience weight regain after stopping GLP-1-based weight loss medication, meaning ongoing treatment may be appropriate for some individuals.
When you’re also taking antidepressants long-term, this means managing two ongoing treatments, each with its own monitoring requirements.
Regular check-ins about both your weight management and mental health can help identify concerns early.
Antidepressant doses should not be adjusted solely because your body weight changes. Whether a dose review is appropriate depends on the specific medication, clinical response, side effects and other relevant factors.
If you decide to stop weight loss medication, be aware that weight regain can occur. This may affect your confidence or emotional wellbeing, particularly if you’ve experienced weight-related distress in the past.
Having a clear maintenance plan, whether that involves continued treatment or other appropriate support, can help you prepare for these changes.
While antidepressants and weight loss injections can sometimes be prescribed together, certain situations require careful attention or immediate action.
Contact your healthcare provider if you experience persistent nausea that interferes with eating, significant fatigue, new physical symptoms or concerns about your medication.
You should not wait a month before reporting severe or persistent gastrointestinal symptoms.
The MHRA’s guidance on GLP-1 medicines explains important safety considerations, including dehydration and serious gastrointestinal complications.
Seek urgent medical assessment if you develop severe, persistent abdominal pain, particularly if it radiates to your back, as this may indicate acute pancreatitis. Severe vomiting, inability to keep fluids down or signs of significant dehydration also require prompt attention.
Contact your mental health provider promptly if you notice worsening depression, increased anxiety that interferes with daily activities, significant sleep changes or loss of interest in activities you normally enjoy.
Seek immediate help if you experience thoughts of self-harm or suicide, detailed plans about ending your life, or feel unable to keep yourself safe.
These symptoms require urgent attention regardless of whether they’re related to your medications.
If there is an immediate risk to life or safety, call 999 or attend A&E. For urgent mental health support in England when there is no immediate emergency, contact NHS 111 and select the mental health option.
Regulatory reviews have not established a causal association between the GLP-1 medicines reviewed and suicidal or self-injurious thoughts and actions. However, this does not mean new or worsening mental health symptoms should be ignored.
Any concerns about your mental health should be assessed promptly, regardless of their suspected cause.
If your psychiatrist or GP wants to change your antidepressant while you’re taking weight loss medication, this requires coordination between your healthcare providers.
Switching antidepressants can affect your mood, appetite and general wellbeing. Your weight loss treatment team should know about the change so they can assess whether any additional monitoring is needed.
Similarly, if you need to stop your weight loss injection temporarily – perhaps due to illness, surgery or side effects – inform the relevant healthcare professionals.
Some GLP-1-based medicines delay gastric emptying, which can be relevant to procedures involving general anaesthesia or deep sedation. Always tell your surgical or anaesthetic team that you’re taking one of these medicines and follow their individual instructions.
Do not independently stop or restart treatment without appropriate advice, particularly if you also have diabetes.
Beyond taking both medications, certain strategies can help support your physical and mental health during treatment.
When appetite-suppressing medication is used alongside antidepressants, ensuring adequate nutrition may require additional attention.
Focus on nutrient-dense foods that provide essential nutrition in manageable portions. Protein is particularly important for maintaining muscle mass during weight loss, while a balanced diet supports general physical and psychological wellbeing.
If you’re struggling to eat enough, protein-rich meals, snacks or smoothies may help. However, persistent difficulties with eating should be discussed with your healthcare provider.
Our Vitamin B12 Spray and Vitamin D3 Spray provide supplementation options where additional intake is appropriate.
However, supplements are not automatically necessary for everyone taking weight loss injections or antidepressants. They should not be presented as treatments for depression or substitutes for a balanced diet.
If your food intake is substantially reduced, your clinician can assess whether nutritional advice, blood tests or supplementation are needed.
Exercise can be a valuable part of managing depression and supporting weight loss. Evidence suggests that regular physical activity can improve depressive symptoms, although it should not automatically replace prescribed antidepressants or psychological treatment.
As you lose weight, movement may become easier and more enjoyable. Even if your antidepressant causes some sedation, finding manageable ways to stay active can support your wellbeing.
Start gently, particularly if you haven’t been active. Brief walks, gentle swimming or simple home exercises may all help.
The goal isn’t intense workouts – it’s regular movement that you can sustain. Outdoor activity may provide additional benefits through social contact, natural light and time spent in nature.
Both antidepressants and changes associated with weight loss can affect sleep patterns.
Some antidepressants cause drowsiness, while others may contribute to insomnia. Gastrointestinal symptoms, changes in eating patterns and other factors can also disrupt sleep.
Yet quality sleep is important for both mental health and weight management.
Prioritise consistent sleep schedules, including weekends where possible. Create a relaxing bedtime routine and reduce activities that interfere with sleep.
If you’re taking mirtazapine, its sedating effects may influence when your clinician recommends taking it. However, you should follow your prescribed schedule rather than changing medication timing independently.
If sleep difficulties persist, discuss them with your healthcare provider.
When you’re managing both mental health and weight loss, stress management becomes particularly important.
Chronic stress can influence mood, eating patterns and sleep. If you’ve previously relied on food to manage difficult emotions, appetite suppression may change how you respond to stress.
Developing healthy coping strategies – mindfulness, deep breathing, yoga, talking with friends or engaging in hobbies – can provide additional ways to manage difficult feelings.
These skills support your mental health and may also help with long-term weight management. However, persistent or severe psychological distress may require professional support.
Successful treatment with both antidepressants and weight loss injections requires appropriate assessment, coordination between healthcare providers and clear communication about your experiences.
When you’re considering weight loss medication and you’re taking antidepressants, your initial consultation should cover your relevant mental health history.
This includes which antidepressant you’re taking, how long you’ve been on it, whether your depression is currently stable, any significant past episodes, and whether you’re seeing a psychiatrist, psychologist or counsellor.
Your prescriber should also review your physical health, current medications, treatment eligibility and any factors that could affect safety.
Be honest about your mental health. Withholding relevant information can prevent your healthcare provider from making a fully informed decision about your care.
At Bodyline, we offer specialised support for patients with mental health considerations, helping ensure your treatment is tailored to your individual circumstances.
Where appropriate, and with your consent, your weight loss treatment team should communicate with your GP and any mental health specialists involved in your care.
This coordination helps ensure everyone understands your health needs and can identify potential concerns.
If you’re seeing a psychiatrist, they should know you’re starting weight loss medication. If your GP prescribes your antidepressant, they should be informed about your weight loss treatment.
This may involve additional communication or appointments, but it can help ensure medication changes and monitoring are properly coordinated.
Regular check-ins are particularly important when you’re taking both types of medication, especially if you have significant mental health needs or experience changes during treatment.
These appointments may cover mood, anxiety, sleep patterns, appetite, nutrition and any concerning thoughts.
Physical health monitoring – including weight, blood pressure, blood glucose where relevant and other assessments based on clinical need – should take place alongside mental health review.
NICE guidance on medicines for managing overweight and obesity provides recommendations on prescribing, monitoring and reviewing weight-management medicines as part of appropriate clinical care.
Don’t wait for scheduled appointments if something concerns you. If you notice significant mood changes, increased anxiety or physical symptoms that worry you, contact your healthcare provider.
Taking weight loss injections while on antidepressants is possible and may be appropriate for many people. But it’s not right for everyone, and the decision should be based on your individual circumstances.
Consider whether your depression is currently stable. If you’re experiencing a severe depressive episode or have recently changed antidepressants, your clinician may recommend additional assessment or support before starting ANY weight loss treatment.
However, a diagnosis of depression or the use of antidepressants does not automatically rule out treatment.
Think about your support systems. Do you have people you can talk to about how you’re feeling? Are you willing to attend monitoring appointments? Do you have strategies for managing stress and difficult emotions beyond eating?
Support systems can make treatment easier to manage, although lacking a strong personal network should not automatically prevent someone from accessing appropriate medical care.
Reflect on your motivations for weight loss. If you’re hoping that losing weight will cure your depression or solve all life’s problems, you may be disappointed.
Weight loss can improve physical health, quality of life and sometimes wellbeing, but it’s not a substitute for mental health treatment. Having realistic expectations supports better decision-making.
If you’re over 70 and taking antidepressants, our specialised support for older adults addresses the unique considerations for this age group, including medication reviews, nutritional needs and other factors that can affect treatment suitability.
Using antidepressants alongside weight loss injections may allow some people to address physical and mental health needs simultaneously, provided the combination is clinically appropriate.
With careful assessment, monitoring and support, many people can continue their prescribed antidepressant treatment while receiving medical weight management.
The key is approaching treatment thoughtfully, with realistic expectations and appropriate medical supervision.
Book a consultation today to discover how we can help you work towards your health goals while prioritising your mental wellbeing. Our team provides personalised care that considers your complete health picture, including your mental health needs and current medications, helping ensure treatment recommendations are appropriate for you as an individual.
BMI calculator
Enter your height and weight to work out your Body Mass Index in seconds.
Your BMI
Find out where you sit and what your options are
Your BMI
Our CQC-regulated clinical team will confirm your eligibility at consultation, in clinic or by video.
CQC regulated 4.8 on Trustpilot
If you'd like advice on your health and wellbeing, our team can talk you through the services we offer.
Explore our servicesWe'd recommend speaking to your GP, who can check everything is OK and offer the right support.
BMI ranges work differently for under 18s. Please speak to your GP for advice.
Please check your height and weight.
Contact us today
Find out more about how we can treat and support you to improve your health and wellbeing.
No-obligation advice from our CQC-regulated team, in clinic or by video.
